ReviewDementia and neurocognitive disorders2026

Druggable Pathophysiologic Targets in Alzheimer Disease: From Amyloid and Tau to Biomarker-Guided Multimodal Therapy.

Jiwon ParkPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.